A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in ...
Apple customers are generally a shockingly loyal bunch. The company's high repeat customer rate can be attributed to a combination of factors that concern iPhones themselves as well as Apple's ...
Sarepta Therapeutics' stock plummets after its gene therapy drug ELEVIDYS fails to meet its primary endpoint in a confirmatory study. SRPT had previously secured accelerated approval for ELEVIDYS to ...
As automakers continue to introduce more EVs, public charging is proving unreliable, according to the latest J.D. Power Electric Vehicle Experience Public Charging study. The study found that 20% of ...
Shares of Altimmune ALT fell 27.04% during market hours on Sep 14, even after the company announced positive top-line results from its 12-week phase I study. The study evaluated pemvidutide in ...
Biohaven Pharmaceuticals BHVN recently announced that the phase II/III HEALY ALS platform study evaluating verdiperstat for treating Amyotrophic Lateral Sclerosis (ALS) failed. ALS is a progressive, ...
A new study finds entrepreneurs become more committed to their business ventures when they are told they will fail, increasing their efforts to make those businesses successful. "Most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results